P

Planet 13 Holdings Inc
CNSX:PLTH

Watchlist Manager
Planet 13 Holdings Inc
CNSX:PLTH
Watchlist
Price: 0.53 CAD Market Closed
Market Cap: 172.3m CAD
Have any thoughts about
Planet 13 Holdings Inc?
Write Note

Relative Value

The Relative Value of one PLTH stock under the Base Case scenario is 0.63 CAD. Compared to the current market price of 0.53 CAD, Planet 13 Holdings Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PLTH Relative Value
Base Case
0.63 CAD
Undervaluation 16%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
70
Median 3Y
1.7
Median 5Y
2.6
Industry
2.5
Forward
0.9
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-19.7
Industry
21.8
Forward
-2.6
vs History
31
vs Industry
11
Median 3Y
-25.7
Median 5Y
-23
Industry
16.1
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-9.3
Industry
23.8
vs History
92
vs Industry
60
Median 3Y
1.3
Median 5Y
1.7
Industry
2.1
vs History
90
vs Industry
76
Median 3Y
1.4
Median 5Y
2.3
Industry
2.7
Forward
0.7
vs History
90
vs Industry
73
Median 3Y
3
Median 5Y
4.3
Industry
5.2
vs History
44
vs Industry
Median 3Y
-14.5
Median 5Y
31.3
Industry
13.5
Forward
13.5
vs History
vs Industry
Median 3Y
-11
Median 5Y
-10.2
Industry
16.8
Forward
-453.5
vs History
31
vs Industry
16
Median 3Y
-19.8
Median 5Y
-16.8
Industry
15.2
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-11.2
Industry
19.3
vs History
96
vs Industry
66
Median 3Y
1
Median 5Y
1.6
Industry
1.9

Multiples Across Competitors

PLTH Competitors Multiples
Planet 13 Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Planet 13 Holdings Inc
CNSX:PLTH
172.3m CAD 1.1 -3.4 34.5 -9.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
162.1B GBP 4.1 31.5 169.4 253.9
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/S Multiple
Revenue Growth P/S to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average P/S: 382 942.1
1.1
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.5
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
4
13%
0.3
US
Merck & Co Inc
NYSE:MRK
4
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average P/E: 32.4
Negative Multiple: -3.4
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average EV/EBITDA: 417.1
34.5
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average EV/EBIT: 2 011.3
Negative Multiple: -9.1
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top